The Alliance for Regenerative Medicine Appoints Rita Johnson-Greene as Chief Operating Officer
March 21, 2023
The Alliance for Regenerative Medicine (ARM), the leading international advocacy organization representing the engineered cell therapy and genetic medicines sector, announced the appointment of Rita Johnson-Greene as Chief Operating Officer, effective April 10.
ARM Releases Statement Responding to Health & Human Services Secretary Becerra’s “Report In Response to the Executive Order on Lowering Prescription Drug Costs for Americans” and Selected Models
February 15, 2023
ARM applauds the HHS announcement that the Center for Medicare and Medicaid Innovation (CMMI) will test a “Cell and Gene Therapy Access Model” to administer multi-state outcomes-based agreements in Medicaid programs for transformative cell and gene therapies.